BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2264420)

  • 1. [Experiences with Rodazol therapy in the treatment of postmenopausal patients with metastatic breast cancer].
    Stier G; Gürtler R; Schmidt UM; Müller U; Tanneberger S
    Zentralbl Gynakol; 1990; 112(17):1101-4. PubMed ID: 2264420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Results of hormone therapy with aminoglutethimide (Rodazol) in postmenopausal metastatic breast cancer].
    Schmidt UM; Brockmann B; Geschke E
    Geburtshilfe Frauenheilkd; 1991 Apr; 51(4):276-9. PubMed ID: 1713564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of metastatic breast cancer with aminoglutethimide after progression on chemotherapy and/or hormonal therapy with tamoxifen.
    Brufman G; Biran S
    Eur J Surg Oncol; 1985 Mar; 11(1):27-31. PubMed ID: 2985452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The use of aminoglutethimide (orimeten) in disseminated breast cancer].
    Nadezhdina TM; Vyshinskaia GV; Lichinitser MR; Bassalyk LS; Garin AM
    Vopr Onkol; 1987; 33(5):79-82. PubMed ID: 3590672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized trial of aminoglutethimide versus tamoxifen in metastatic breast cancer.
    Lipton A; Harvey HA; Santen RJ; Boucher A; White D; Bernath A; Dixon R; Richards G; Shafik A
    Cancer Res; 1982 Aug; 42(8 Suppl):3434s-3436s. PubMed ID: 7044526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aminoglutethimide in the treatment of advanced postmenopausal breast cancer.
    Harris AL; Powles TJ; Smith IE
    Cancer Res; 1982 Aug; 42(8 Suppl):3405s-3408s. PubMed ID: 7083207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aminoglutethimide in the treatment of metastatic breast cancer.
    Troner MB
    Cancer Res; 1982 Aug; 42(8 Suppl):3402s-3404s. PubMed ID: 7083206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Aminoglutethimide therapy in advanced breast cancer].
    Kühböck J; Ludwig H; Pötzi P; Zielinski C
    Wien Med Wochenschr; 1985 Dec; 135(23-24):608-11. PubMed ID: 4096007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aminoglutethimide as second line endocrine therapy in advanced breast cancer.
    Brufman G; Biran S
    Anticancer Res; 1986; 6(5):1065-8. PubMed ID: 3800315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aminoglutethimide after tamoxifen therapy in advanced breast cancer: M. D. Anderson Hospital experience.
    Buzdar AU; Powell KC; Blumenschein GR
    Cancer Res; 1982 Aug; 42(8 Suppl):3448s-3450s. PubMed ID: 7083209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experience with 6-aminoglutethimide in the treatment of metastatic breast cancer.
    Koelmeyer TD; Stephens EJ; Wood HF
    Clin Oncol; 1978 Dec; 4(4):323-7. PubMed ID: 729221
    [No Abstract]   [Full Text] [Related]  

  • 12. [Low-dose aminoglutethimide (500 mg/day) and hydrocortisone (30 mg/day) in advanced cancer of breast].
    Bonneterre J; Pion JM; Demaille A
    Bull Cancer; 1987; 74(3):241-7. PubMed ID: 3304478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is aminoglutethimide an alternative to adrenalectomy for metastatic carcinoma of the breast?
    Sterns EE; Bird CE; Mackie KW
    Can J Surg; 1982 Nov; 25(6):695-7. PubMed ID: 7139430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aminoglutethimide without hydrocortisone in the treatment of postmenopausal patients with advanced breast cancer.
    Höffken K; Kempf H; Miller AA; Miller B; Schmidt CG; Faber P; Kley HK
    Cancer Treat Rep; 1986 Oct; 70(10):1153-7. PubMed ID: 3756937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tamoxifen versus aminoglutethimide versus combined tamoxifen and aminoglutethimide in the treatment of advanced breast carcinoma.
    Smith IE; Harris AL; Morgan M; Gazet JC; McKinna JA
    Cancer Res; 1982 Aug; 42(8 Suppl):3430s-3433s. PubMed ID: 7044525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hormone therapy of metastatic breast carcinoma].
    Höffken K; Miller AA; Miller B; Becher R; Schmidt CG
    Dtsch Med Wochenschr; 1985 Nov; 110(47):1799-802. PubMed ID: 3933941
    [No Abstract]   [Full Text] [Related]  

  • 17. [2d and 3d line hormonal therapy in postmenopausal metastatic breast tumor. Comparison of medroxyprogesterone acetate and aminoglutethimide in tamoxifen-resistant patients].
    Garcia-Giralt E; Omodei Zorini C; Ferri L; Ayme Y; Carton M; Daban A; Delozier T; Fargeot P; Fumoleau P; Gorins A
    Clin Ter; 1994 Aug; 145(8):113-21. PubMed ID: 7955956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The use of aminoglutethimide in the treatment of metastatic breast cancer].
    Bellora MG; Ciancio A; Ferrero A; Bergamino T; Zola P; Sismondi P
    Minerva Ginecol; 1991 Dec; 43(12):589-93. PubMed ID: 1819778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aminoglutethimide as second line therapy in advanced breast cancer.
    Elomaa I; Blomqvist C; Rissanen P
    Breast Cancer Res Treat; 1986; 7 Suppl():S51-4. PubMed ID: 3017481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of metastasizing breast cancer with aminoglutethimide].
    Kübböck J; Ludwig H; Aiginger P; Linkesch W; Pötzi P
    Acta Med Austriaca; 1982; 9(5-6):221-6. PubMed ID: 7164757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.